NORADRENALINE MEDICIANZ noradrenaline (norepinephrine) (as acid tartrate monohydrate) 8 mg/8 mL concentrated injection ampoule

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

noradrenaline (norepinephrine) acid tartrate monohydrate, Quantity: 16 mg/mL (Equivalent: noradrenaline (norepinephrine), Qty 8 mg/mL)

Available from:

Medsurge Pharma Pty Ltd

Pharmaceutical form:

Injection, concentrated

Composition:

Excipient Ingredients: water for injections; hydrochloric acid; sodium chloride

Administration route:

Intravenous

Units in package:

10 x 8 mL

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

For the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,As an adjunct in the treatment of cardiac arrest. To restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Product summary:

Visual Identification: Clear colourless or yellowish solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2022-03-01